Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF mutations in Iranian patients with papillary thyroid carcinoma.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2013

Ranjbari Nastran, Almasi Shekoufeh, Mohammadi-Asl Javad, Rahim Fakher

Abstract excerpt

BACKGROUND: Papillary thyroid cancer or papillary thyroid carcinoma (PTC) is the most common thyroid cancer. The fact that it occasionally occurs in women aged 30-40 years old suggests that genetic alterations are involved its genesis. Recently, activator mutations in BRAF gene have been relative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to DNA, Neoplasm
Share to Iran

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Paraffin Embedding

Share to Polymorphism, Restriction Fragment Length

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 23725167
DOI: 10.7314/apjcp.2013.14.4.2521

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23725167-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF mutations in Iranian patients with papillary thyroid carcinoma.PMID 23725167Read ↗

Correlation between polymorphisms of BRAF gene and papillary thyroid carcinoma.Semantic proximity Read ↗

BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness.Semantic proximity Read ↗

Analysis of the association of BRAFV600E mutation and Ki-67 overexpression with clinical and pathological characteristics in papillary thyroid cancer.Semantic proximity Read ↗

Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case seriesSemantic proximity Read ↗

BRAF<sup>V600E</sup> Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid CancerSemantic proximity Read ↗

The Frequency and Clinical Implications of the BRAFV600EMutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two DecadesSemantic proximity Read ↗

BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic.Semantic proximity Read ↗

BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates.Semantic proximity Read ↗

Prevalence and Clinicopathological Significance of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Retrospective Cohort Study from Kerala, IndiaSemantic proximity Read ↗

Targeting of the BRAF gene in papillary thyroid carcinoma (review).Semantic proximity Read ↗

BRAF and RET polymorphism association with thyroid cancer risk, a preliminary study from Khyber Pakhtunkhwa population.Semantic proximity Read ↗

[Correlation between BRAF V600E mutation and clinicopathologic features of papillary thyroid carcinoma].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.